US2017107269A1PendingUtilityA1

Sperm-Specific Cation Channel, and Uses Therefor

Assignee: CHILDREN'S MEDICAL CENTER CORPPriority: May 3, 2001Filed: Aug 19, 2016Published: Apr 20, 2017
Est. expiryMay 3, 2021(expired)· nominal 20-yr term from priority
A61P 43/00A61P 15/08A01K 2267/03G01N 33/5044A61P 15/18C07K 14/705A01K 2227/105G01N 33/68A61P 15/00A01K 2217/052A61P 15/16A01K 2227/106G01N 33/5029A01K 67/0278G01N 33/5041C07K 16/28C07K 16/18
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Nucleic acid and protein sequences relating to a cation channel which is sperm-specific (CatSper1) are disclosed. The CatSper1 protein is shown to be specifically expressed in sperm and to be necessary for sperm motility. Nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies relating to the CatSper1 gene and protein are disclosed. Also provided are methods of in vitro fertilization and contraception, methods of identifying modulators of CatSper1 activity, methods of genotyping subjects with respect to CatSper1, and methods of diagnosing and treating CatSper1-mediated disorders, including infertility.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A transgenic non-human animal comprising a modification into the non-human animal, the modification comprising an insertion of a nucleic acid encoding a CatSper1 protein, the CatSper1 protein comprising at least 90% similarity to the amino acid sequence of SEQ ID NO: 4, and wherein the CatSper1 protein has CatSper1 activity. 
     
     
         2 . A transgenic non-human animal comprising a modification into the non-human animal, wherein the modification is replacement of an endogenous CatSper1 protein sequence with a reporter or marker gene, wherein the CatSper1 protein comprises at least 90% similarity to the amino acid sequence of SEQ ID NO: 4. 
     
     
         3 . A transgenic non-human animal comprising a modification into the non-human animal, the modification comprising inactivation of an endogenous CatSper1 protein, wherein the CatSper1 protein comprises at least 90% similarity to the amino acid sequence of SEQ ID NO: 4. 
     
     
         4 . The transgenic non-human animal of  claim 1 , wherein the modification is by homologous recombination to result in expression of the reporter gene. 
     
     
         5 . The transgenic non-human animal of  claim 1 , wherein the modification is by homologous recombination to result in expression of the marker gene. 
     
     
         6 . The transgenic non-human animal of any one of  claims 1 - 3 , wherein the CatSper1 sequences are conspecific to the transgenic animal. 
     
     
         7 . The transgenic non-human animal of any one of  claims 1 - 3 , wherein the CatSper1 sequences are transpecific to the transgenic animal. 
     
     
         8 . The transgenic non-human animal of any one of  claims 1 - 3 , wherein the animal is a mouse, rat, hamster, guinea pig, rabbit, dog, cat, goat, sheep, pigs, or a non-human primate. 
     
     
         9 . The transgenic non-human animal of any one of  claims 1 - 3 , wherein the animal is a mouse. 
     
     
         10 . The transgenic non-human animal of any one of  claims 1 - 3 , wherein the animal is a non-human primate.

Join the waitlist — get patent alerts

Track US2017107269A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.